Effects of preoperative proton pump inhibitor administration on bleeding after gastric endoscopic submucosal dissection: A systematic review and meta-analysis

Toshihiro Nishizawa, Hidekazu Suzuki, Teppei Akimoto, Tadateru Maehata, Toshio Morizane, Takanori Kanai, Naohisa Yahagi

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background and aim: The efficacy of using proton pump inhibitors (PPIs) prior to gastric endoscopic submucosal dissection (ESD) to reduce gastric bleeding remains controversial. This study aimed to systematically review the literature to evaluate the efficacy of preoperative PPI use to reduce post-ESD bleeding. Methods: PubMed, the Cochrane library, and the Igaku-Chuo-Zasshi database were searched to identify randomized trials eligible for inclusion in the systematic review. Data from four studies (406 patients) were combined to calculate a pooled risk difference (RD) for developing post-ESD bleeding. Results: Compared with patients who received no premedication, the pooled RD for post-ESD bleeding in patients who received preoperavive PPI was –0.027 (95% confidence interval: –0.070–0.017, p=0.228), without significant heterogeneity. Preoperavive PPI use significantly increased gastric pH (weighted mean difference: 1.289, 95% CI: 0.227–2.352, p=0.0174). Conclusions: This systematic review and meta-analysis showed that premedication with PPI had no advantage for the prevention of post-ESD bleeding, despite increasing gastric pH.

Original languageEnglish
Pages (from-to)5-10
Number of pages6
JournalUnited European Gastroenterology Journal
Volume4
Issue number1
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Proton Pump Inhibitors
Meta-Analysis
Stomach
Hemorrhage
Premedication
PubMed
Libraries
Endoscopic Mucosal Resection
Databases
Confidence Intervals

Keywords

  • Gastric bleeding
  • Gastric endoscopic submucosal dissection
  • Premedication
  • Proton pump inhibitor
  • Systematic review

ASJC Scopus subject areas

  • Gastroenterology
  • Oncology

Cite this

Effects of preoperative proton pump inhibitor administration on bleeding after gastric endoscopic submucosal dissection : A systematic review and meta-analysis. / Nishizawa, Toshihiro; Suzuki, Hidekazu; Akimoto, Teppei; Maehata, Tadateru; Morizane, Toshio; Kanai, Takanori; Yahagi, Naohisa.

In: United European Gastroenterology Journal, Vol. 4, No. 1, 01.01.2016, p. 5-10.

Research output: Contribution to journalArticle

@article{5790525dbf95448f86ed7ba9c5bb4b9a,
title = "Effects of preoperative proton pump inhibitor administration on bleeding after gastric endoscopic submucosal dissection: A systematic review and meta-analysis",
abstract = "Background and aim: The efficacy of using proton pump inhibitors (PPIs) prior to gastric endoscopic submucosal dissection (ESD) to reduce gastric bleeding remains controversial. This study aimed to systematically review the literature to evaluate the efficacy of preoperative PPI use to reduce post-ESD bleeding. Methods: PubMed, the Cochrane library, and the Igaku-Chuo-Zasshi database were searched to identify randomized trials eligible for inclusion in the systematic review. Data from four studies (406 patients) were combined to calculate a pooled risk difference (RD) for developing post-ESD bleeding. Results: Compared with patients who received no premedication, the pooled RD for post-ESD bleeding in patients who received preoperavive PPI was –0.027 (95{\%} confidence interval: –0.070–0.017, p=0.228), without significant heterogeneity. Preoperavive PPI use significantly increased gastric pH (weighted mean difference: 1.289, 95{\%} CI: 0.227–2.352, p=0.0174). Conclusions: This systematic review and meta-analysis showed that premedication with PPI had no advantage for the prevention of post-ESD bleeding, despite increasing gastric pH.",
keywords = "Gastric bleeding, Gastric endoscopic submucosal dissection, Premedication, Proton pump inhibitor, Systematic review",
author = "Toshihiro Nishizawa and Hidekazu Suzuki and Teppei Akimoto and Tadateru Maehata and Toshio Morizane and Takanori Kanai and Naohisa Yahagi",
year = "2016",
month = "1",
day = "1",
doi = "10.1177/2050640615588023",
language = "English",
volume = "4",
pages = "5--10",
journal = "United European Gastroenterology Journal",
issn = "2050-6406",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Effects of preoperative proton pump inhibitor administration on bleeding after gastric endoscopic submucosal dissection

T2 - A systematic review and meta-analysis

AU - Nishizawa, Toshihiro

AU - Suzuki, Hidekazu

AU - Akimoto, Teppei

AU - Maehata, Tadateru

AU - Morizane, Toshio

AU - Kanai, Takanori

AU - Yahagi, Naohisa

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Background and aim: The efficacy of using proton pump inhibitors (PPIs) prior to gastric endoscopic submucosal dissection (ESD) to reduce gastric bleeding remains controversial. This study aimed to systematically review the literature to evaluate the efficacy of preoperative PPI use to reduce post-ESD bleeding. Methods: PubMed, the Cochrane library, and the Igaku-Chuo-Zasshi database were searched to identify randomized trials eligible for inclusion in the systematic review. Data from four studies (406 patients) were combined to calculate a pooled risk difference (RD) for developing post-ESD bleeding. Results: Compared with patients who received no premedication, the pooled RD for post-ESD bleeding in patients who received preoperavive PPI was –0.027 (95% confidence interval: –0.070–0.017, p=0.228), without significant heterogeneity. Preoperavive PPI use significantly increased gastric pH (weighted mean difference: 1.289, 95% CI: 0.227–2.352, p=0.0174). Conclusions: This systematic review and meta-analysis showed that premedication with PPI had no advantage for the prevention of post-ESD bleeding, despite increasing gastric pH.

AB - Background and aim: The efficacy of using proton pump inhibitors (PPIs) prior to gastric endoscopic submucosal dissection (ESD) to reduce gastric bleeding remains controversial. This study aimed to systematically review the literature to evaluate the efficacy of preoperative PPI use to reduce post-ESD bleeding. Methods: PubMed, the Cochrane library, and the Igaku-Chuo-Zasshi database were searched to identify randomized trials eligible for inclusion in the systematic review. Data from four studies (406 patients) were combined to calculate a pooled risk difference (RD) for developing post-ESD bleeding. Results: Compared with patients who received no premedication, the pooled RD for post-ESD bleeding in patients who received preoperavive PPI was –0.027 (95% confidence interval: –0.070–0.017, p=0.228), without significant heterogeneity. Preoperavive PPI use significantly increased gastric pH (weighted mean difference: 1.289, 95% CI: 0.227–2.352, p=0.0174). Conclusions: This systematic review and meta-analysis showed that premedication with PPI had no advantage for the prevention of post-ESD bleeding, despite increasing gastric pH.

KW - Gastric bleeding

KW - Gastric endoscopic submucosal dissection

KW - Premedication

KW - Proton pump inhibitor

KW - Systematic review

UR - http://www.scopus.com/inward/record.url?scp=84979464827&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84979464827&partnerID=8YFLogxK

U2 - 10.1177/2050640615588023

DO - 10.1177/2050640615588023

M3 - Article

AN - SCOPUS:84979464827

VL - 4

SP - 5

EP - 10

JO - United European Gastroenterology Journal

JF - United European Gastroenterology Journal

SN - 2050-6406

IS - 1

ER -